Don't Buy UnitedHealth Group Stock Before Jan. 27
The Motley Fool••business
Key Points:
- UnitedHealth Group's stock has declined about 34% in 2025 amid rising costs and a suspended profit forecast, marking its first earnings miss in over a decade.
- The company is set to release its full-year 2025 results and 2026 financial guidance on January 27, which is crucial for clarifying its profitability and growth outlook.
- Investors should focus on key metrics in the guidance report, including earnings per share (EPS), medical care ratio (MCR), and operating margin to assess the company’s financial health.
- A 2026 EPS projection significantly higher than the 2025 adjusted EPS of $16.25, an MCR near the mid-80% range, and an operating margin around
